SCHEMBL13285584

SCHEMBL13285584

C#Cc1cccc(Nc2ncnc3cc(O)c(OC)cc23)c1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.83
GAK O14976 3/20 0.83
FBP1 P09467 2/20 0.83
ALDH1A1 P00352 1/20 0.83
MAPT P10636 1/20 0.83
ERBB2 P04626 6/20 0.69
RET P07949 4/20 0.69
KDR P35968 4/20 0.69
ABCG2 Q9UNQ0 2/20 0.69
ILK Q13418 2/20 0.69
FLT1 P17948 2/20 0.69
CDK2 P24941 2/20 0.69
RIPK2 O43353 2/20 0.69
BUB1 O43683 2/20 0.69
STK10 O94804 2/20 0.69
ABL1 P00519 2/20 0.69
LCK P06239 2/20 0.69
LYN P07948 2/20 0.69
SRC P12931 2/20 0.69
FGFR2 P21802 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644810 0.96 EGFR (0.83) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL28286584 0.95 EGFR (0.82) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL667895 0.91 EGFR (1.00) EGFRGAKFBP1ALDH1A1MAPT
Acetic Acid SCHEMBL28392670 0.91 EGFR (0.76) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL1507455 0.90 EGFR (0.98) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL1507585 0.89 EGFR (0.85) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL256396 0.87 EGFR (0.69) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL8684647 0.86 EGFR (0.77) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL3873473 0.86 EGFR (0.67) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL15946889 0.86 EGFR (0.85) EGFRGAKFBP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11083793-B2 Epidermal growth factor receptor (EGFR) targeted photosensitizers HEALTH RESEARCH, INC. (US) 2021-08-10 US disclosed
WO-2010085747-A1 STEROIDAL ANTI-HORMONE HYBRIDS NORTHEASTERN UNIVERSITY (US) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11083793-B2 Epidermal growth factor receptor (EGFR) targeted photosensitizers EGFR, ERBB2, ERBB4 EGFR 1/4885GAK 531/4885FBP1 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.